Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Dustin’s CEO increases his shareholding through subscription for new shares in incentive program

Dustin CEO Thomas Ekman has subscribed for 25,500 new shares through warrants purchased in the long-term incentive program introduced at the annual general meeting on January 19, 2016. After the subscription of new shares Thomas Ekman will hold a total of 33,500 shares in the company. Contact person: Eva Ernfors, Head of Information; eva.ernfors@dustin.se, +46 70 258 62 94 About Dustin Dustin is a leading online based IT-partner with operations in the Nordics and the Netherlands. The Company offers IT products with associated services and solutions to companies, the public

Interim Report January – March 2019

Solid financial result. Startup of ZYN production in the US · In local currencies, sales increased by 3 percent for the first quarter. Reported sales increased by 11 percent to 3,258 MSEK (2,941). · In local currencies, operating profit from product segments1) increased by 7 percent for the first quarter. Reported operating profit from product segments increased by 15 percent to 1,238 MSEK (1,079). · Operating profit amounted to 1,190 MSEK (1,047) for the first quarter. · Profit after tax amounted to 880 MSEK (766) for the first quarter. · Earnings per share increased by 19

Photocure ASA: Invitation to first quarter 2019 results presentation and webcast

Photocure will present its first quarter report on Tuesday 14 May 2019 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET).Representatives from the company will be Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English. The quarterly report and presentation will be published at 07:00 CET and will be publicly available at www.photocure.com. It will be possible to follow the presentation through https://webtv.hegnar.no/presentation.php?webcastId=97815786.  A light snack will be served from 08:00 (CET). The presentation is scheduled

Norway Royal Salmon: Notice to Annual General Meeting

Attached please find the notice to the Annual General Meeting in Norway Royal Salmon ASA (the "Company"), to be held in Trondheim 6(th) June 2019. The notice will be sent to all shareholders by post no later than 10(th) May 2019. The board of directors proposes a distribution of dividend for 2018 of NOK 6.00 per share, by the way of a cash distribution of NOK 4.20 per share and distribution of shares in the Company from the Company's treasury shares. The number of shares for distribution in total and per outstanding share will be decided based on the shares' volume weighted average

Humana reports first quarter results 2019

A good start to the year clouded by challenges in Individual & FamilyFirst quarter, January - March 2019  ·  Operating revenue was SEK 1,708 M (1,648), an increase of 4%. ·  Operating profit was SEK 77 M (81), a decrease of 5%. Excluding the effects of IFRS 16, which apply from 1 January 2019, the operating profit amounted to SEK 70 M (81). ·  Net profit after tax for the period amounted to SEK 44 M (45). ·  Earnings per share for the period before and after dilution amounted to SEK 0.83 (0.85). ·  Operating cash flow amounted to SEK 33 M (-32). Excluding the effects of

Ziccum Q1 Report 2019 released

(Stockholm May 9, 2019)  Ziccum AB today releases its Q1 Report for 2019. The Report is now available on the company’s website.Summary of interim report - first quarter 2019: Successful development of a dry, temperature-stable formulation of Adenovirus resulted in a filed patent application and a significant milestone for Ziccum. Dialogue with potential Customers and partners continue with increased intensity, and an application has been submitted to Horizon 2020 step 2. January - March 2019 Net sales SEK 0,0 (190) Operating profit SEK -1,689 thousand (-137) Earnings per share

Annual General Meeting in Fastighets AB Balder (PUBL)

The Annual General Meeting (AGM) of Fastighets AB Balder (publ) was held on 8 May, 2019 in Gothenburg.Christina Rogestam, Chairman of the Board, opened the meeting and was elected Chairman of the AGM.Erik Selin, CEO, reported on the company´s operations during 2018.The income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet for 2018 were adopted. The Board members and the CEO were discharged from liability for their administration during the 2018 fiscal year.The AGM resolved that the shareholders shall not obtain any

Invitation to presentation in conjunction with Net Gaming's first quarter of 2019

On Thursday 23 May at 08:30 a.m. CET Net Gaming's interim report for the first quarter of 2019, will be published. At 10:00 a.m. the same day a presentation of Net Gaming's interim report for the first quarter of 2019, will be presented.CEO Marcus Teilman and CFO Gustav Vadenbring will present the results, followed by a Q&A session. The presentation will be held in English and will be webcasted live through netgaming.se or via https://tv.streamfabriken.com/net-gaming-europe-q1-2019 The join the conference via phone, please dial-in using any of the numbers below: From Sweden:

Interim report for Q1 2019

A stable beginning of the yearThe beginning of 2019 was stable. Revenues increased somewhat, while the EBITDA result and margin greatly improved. 2018 was an exciting and eventful year for Bactiguard when we reached several important milestones, so we have high expectations for 2019.First quarter (January-March 2019) · Revenues amounted to SEK 35.1 (33.0) million, an increase mainly driven by higher license revenues. · BIP sales amounted to SEK 3.1 (7.3) million. No deliveries were made to China and India this quarter, while first quarter of 2018 contained major deliveries to both

Clavister Q1 2019: 38% growth

May 9, 2019. Örnsköldsvik, Sweden. Clavister, a leader in high-performance cybersecurity solutions, released its Q1 2019 interim report today.“The first quarter of the year provided for a 38% order intake growth, year-on-year.Our focus markets Nordics and the DACH region continued to demonstrate high growth, and in DACH specifically we were able to on-board a significant number of new reseller partners.Apart from a relentless focus on sales growth, the year for Clavister will be dominated by a flood of new and exciting product launches. 2019 alone will see more new products from

Annual General Meeting of BioGaia

The Annual General Meeting of BioGaia AB (publ) on 8 May 2019 voted, among other things, to approve the following resolutions: · adoption of the annual report · discharge from liability for the Board members and the Managing Director · a dividend of SEK 10.00 per share and a grant of SEK 3.2 million to “The foundation to prevent antibiotic resistance” that was founded by BioGaia in 2017. The purpose of the foundation is to reduce antibiotic resistance through support to research, education and information activities that promote of the use of products and methods that prevent

Interim report for the period January 1 - March 31, 2019

Net sales increased during the quarter to SEK 22.5 million (0.0) and operating profit improved to SEK -16.9 million (-20.1) attributable to deliveries within geothermal. The increase in value in Baseload Capital resulted in an improved profit after financial items SEK -7.3 million (-20.5). However, external factors in the form of customers' permitting processes within geothermal remain a challenge that extends current lead times. In total, the order backlog amounted to SEK 799.3 million (404.3) at the end of the quarter.FIRST QUARTER 2019 JANUARY – MARCH · Net sales increased to SEK

Angler Gaming plc - Interim Report for 1st Quarter of 2019

EBIT increased by 70% compared to the previous quarter (Q4 2018)· Revenues increased by 56.47% to €6,303,333 (Q1 2018: €4,028,577) · EBIT decreased by 11.17% to €1,216,127 (Q1 2018: €1,369,075) · EBIT increased by 70.06% compared to Q4 2018 (Q4 2018: € 715,128) · EBIT margin of 19.29% (Q1 2018: 33.98%) · Customer deposits increase of 141.22% to €16,324,713 (Q1 2018: €6,767,565) · 36,100 new registered customers (Q1 2018: 35,237), an increase of 2.45% · 33,303 active customers (Q1 2018: 21,203), an increase of 57.07%. · Earnings per share of €0.0146 (Q1 2018: €0.0178).

Interim Report January – March 2019

BioArctic’s partner Eisai initiated Phase 3-study with BAN2401 in Alzheimer’s disease. Phase 1-study with ABBV-0805 in the Parkinson program startedFinancial summary for the period January – March 2019 · Net revenues for the period amounted to MSEK 63.4 (52.3), which is an increase of MSEK 11.1 · Operating profit amounted to MSEK 17.3 (18.9), a decrease of MSEK 1.6. The operating margin was 27.3 percent (36.1) · Profit for the period amounted to MSEK 13.6 (15.4) and earnings per share1were SEK 0.15 (0.18) · Cash flow from operating activities amounted to MSEK 333.6 (-42.0)

Nuevolution’s BET-BD1 selective inhibitor and candidate compound, NUE20798, shows positive effect on disease scoring and biomarker levels in an atopic dermatitis (eczema) mouse model

Stockholm, 9 May 2019. Nuevolution AB (publ) (NUE.ST) today announced completion of positive data for NUE20798 from an atopic dermatitis (eczema) mouse model showing reduction of both disease - and clinical biomarker levels. No negative effect was observed on the blood platelet count (so-called thrombocytopenia) when using Nuevolution’s selective bromodomain inhibitor NUE20798. Nuevolution has developed potent and selective compounds, with a benign safety profile targeting the first bromodomain of the BET family of proteins and recently nominated NUE20798 as its development candidate.

Increased number of shares entered into trade register

Revenio Group Corporation, Stock Exchange Release, May 9, 2019 at 9:00INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER Total of 6,270 new share subscriptions based on the company's 2015A stock options approved by the Board of Directors of Revenio Group Corporation on April 29, 2019, have been entered into the trade register today. The share subscription price under 2015A option rights was 7.95 EUR per share. The subscription period for 2015A options is May 31, 2017 – May 31, 2019. After these subscriptions, the number of Revenio Group Corporation's shares and votes will rise to

Stora Enso explores recycling of paper cups for magazine paper production

STORA ENSO OYJ PRESS RELEASE 09 May 2019 at 9.00 EESTStora Enso aims to start recycling used paper cups on a large scale at its Langerbrugge Mill in Belgium. Based on production trials, Stora Enso possesses the technical feasibility to recycle paper cups for use in other paper applications. Stora Enso is now looking into partnerships for the collection and sorting of used paper cups to ensure that this high-quality fibre material is captured and given a second life. Recycled fibre is an important raw material for Stora Enso as it is aligned with the company’s commitment towards a

Scandi Standard (SCST SS) – Organisational changes

Scandi Standard is pleased to announce the appointment of Ado Carton as CEO of Manor Farm and member of Group Management with effect from 1th of June 2019. He is replacing Vincent Carton as part of a management succession plan following the 2017 acquisition of Manor Farm. Prior to joining Scandi Standard, Carton came from Kerry Group, a leading manufacturer and marketer of added value branded and customer branded chilled foods to the UK, Irish and continental European consumer foods markets. Through his 27 years career with Kerry Group he held an array of key management positions, most

Terveystalo Plc: Terveystalo Group Interim report 1 January -31 March 2019

Growth in all customer groups, Attendo integration on track Terveystalo Plc Interim report 9 May 2019 at 9:00 am EEST This release is a summary of Terveystalo's Interim Report for 1 January – 31 March 2019. The full release is available as an attachment to this stock exchange release and is available on our website at https://www.terveystalo.com/en/investors/Financial-information/. January–March 2019 in brief · Revenue increased by 35.6 percent year-on-year to EUR 267.8 million (197.5) · Revenue excluding Attendo's Finnish Health Services increased by 5.5 percentto EUR

Financial Report 2018/19 1 April 2018-31 March 2019

Financial year 2018/19 (1 April 2018-31 March 2019) · Revenue increased by 7 percent to MSEK 6,024 (5,616). · Operating profit (excluding items affecting comparability in the preceding year) rose by 20 percent to MSEK 302 (252), corresponding to an operating margin of 5.0 percent (4.5). · EBITA increased by 21 percent to MSEK 318 (262), corresponding to an EBITA margin of 5.3 percent (4.7). · Profit after financial items rose by 26 percent to MSEK 296 (235). · Net profit increased by 27 percent to MSEK 231 (182). · Earnings per share totalled SEK 8.20 (6.45). · Cash

ContextVision - Annual General Meeting 2019

On the 8th of May 2019, ContextVision held its ordinary Shareholders' Annual General Meeting in Stockholm. -       The annual financial report regarding 2018 was presented and approved by the AGM. -       Disposition of financial results according to the proposal of the Board of Directors was approved. -       The Managing Director and the Board of Directors were discharged from liability. -       Board compensation was decided according to the following:·   The chairman of the board will be paid SEK 300.000 for the period until next AGM.·   Other members of the board,

Utilization of transfer authorization in Investor AB

The Annual General Meeting of Investor 2019 decided to authorize the company’s Board to decide on the transfer of the company’s own shares in order to, among other things, secure costs for Investor’s long-term variable remuneration program for employees within Investor and for the issue of synthetic shares as part of the Board remuneration. Investor hereby announces that the company’s Board has decided to utilize the authorization for these purposes.The transfer of own shares may take place on Nasdaq Stockholm during the period from May 9, 2019 up to and including May 5, 2020 at a price

Interim report January – March 2019

RaySearch Laboratories AB (publ)“The year started on a strong note for RaySearch: in the first quarter, order intake rose 57 percent and net sales rose 49 percent”Johan Löf, CEO of RaySearch. CEO comments on page 2.  THE QUARTER IN BRIEFIn the first quarter of 2019, order intake rose 57 percent to SEK 202 M (128). Net sales rose 49 percent to SEK 173 M (116) and the operating margin increased to 13 percent (12).  FIRST QUARTER (JANUARY-MARCH 2019) · Net sales SEK 173.1 M (116.3), of which revenue from RayStation®/RayCare® SEK 163.1 M (104.2) · Profit after tax SEK 17.2 M (

HiQ Sailing Team aims for a new record

HiQ celebrates 20 years on the stock market by trying to break the Gotland Runt sailing competition record. Again. “Eleven years ago, we beat the speed record around Gotland with trimaran HiQ III. Now we’re also aiming to break the monohull record with the HiQ IV,” says Erik Ridman, Head of Communications at HiQ.HiQ is since long a successful competitor at the offshore racing scene with the sailing project HiQ Sailing Team. HiQ’s well-known 60-foot trimaran was one of the world’s fastest sailboats, beating several records over the years. The Team’s most spectacular record was Gotland Runt

There are no items matching the current filter
There are no more items matching the current filter
Back to top